New York State is closer to legalizing medical marijuana as lawmakers slowly start to support it. The matter is expected to be discussed later this month when the legislators convene after the Easter break.
However, it is still unclear whether the drug will be sourced from legal sources as permitted under the proposed medical marijuana bill or from Gov. Andrew Cuomo’s research program.
According to a Food and Drug Administration spokeswoman, marijuana for medical trials is being sourced from the National Institute on Drug Abuse, which is locked in a contract with the University of Mississippi to cultivate marijuana for research.
“Obtaining marijuana for research along these lines is notoriously difficult, but not impossible,” Gabriel Sayegh, the New York state director of the Drug Policy Alliance told Wall Street Journal.
Proponents of the medical marijuana argue that the drug can relieve loss of appetite, nausea and extreme pain associated with conditions such as epilepsy, cancer or Aids. A version of the drug, which is low in THC, has been shown to combat seizures. This was confirmed by FDA’s decision to allow the testing of a marijuana-based drug developed by a British firm that can deal with seizures.
It is still not clear how the medical marijuana will be transported into the New York State without breaking federal law that bars the transportation of marijuana across state borders.
When contacted on the issue, Assemblyman Richard Gottfried and Senator Diane Savino, who are sponsors of the medical marijuana bill, refused to comment. To register for a free 2-week subscription to ForexMinute Premium Plan, visit www.forexminute.com/newsletter.
To contact the reporter of this story; Jonathan Millet at firstname.lastname@example.org